Skip to search formSkip to main contentSkip to account menu

PRKACA protein, human

Known as: cAMP-Dependent Protein Kinase Catalytic Subunit Alpha, protein kinase, cAMP-dependent, catalytic, alpha protein, human, cAMP-Dependent Protein Kinase Alpha 
cAMP-dependent protein kinase catalytic subunit alpha (351 aa, ~41 kDa) is encoded by the human PRKACA gene. This protein plays a role in protein… 
National Institutes of Health

Related topics

Related topics

24 relations
ApoptosisCentrosome PathwayCyclic AMP-Dependent Protein KinasesERBB2/ERBB3 Signaling Pathway

Broader (1)

Cyclic AMP-Dependent Protein Kinase Catalytic Subunits

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.
Protein kinase A (PKA) regulatory subunit type 1A (PRKAR1A) defects lead to primary pigmented nodular adrenocortical disease… 
2018
2018
Abstract B37: Assessing DNA damage response pathway proteins ATM and p53 in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein
Introduction: Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of liver cancer that is prevalent in younger… 
2018
2018
Abstract 4150: MDM4 expression is increased in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein
Introduction: Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma (HCC) that… 
2017
2017
Abstract 3514: Assessing the role of CREB in fibrolamellar hepatocellular carcinoma with PRKACA-DNAJB1 fusion protein
Introduction: Fibrolamellar Hepatocellular Carcinoma (FLHCC) is a rare form of liver cancer that occurs predominantly in… 
2016
2016
Protein kinase, cAMP-dependent, alpha catalytic subunit (PRKACA) mutation in adrenal Cushing’s syndrome in Korean patients
................................................................................. i 
2014
2014
Neuroendocrine cancer: An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics
An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics New genetic findings might have… 
2014
2014
Constitutive activation of PRKACA in adrenal Cushing's syndrome
2014
2014
Abstract LB-182: Constitutive activation of PRKACA in adrenal Cushing's syndrome
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Corticotropin-independent Cushing's syndrome may be caused… 
2011
2011
Overcoming Resistance to Trastuzumab in HER2-Amplified Breast Cancers
Abstract : The receptor tyrosin kinase HER2 is amplified and/or overexpressed in 25-30% of all breast cancers. Blockade of HER2… 
2011
2011
Association between LRRK 2 and 4 EBP 1 protein levels in normal and malignant cells
Translational control is a crucial component of cancer development and progression. Eukaryotic initiation factor (eIF) 4E… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)